AVVAA Signs Distribution Agreement with Natural Product Distributor
October 21 2013 - 9:00AM
OTC Markets
Richmond, Virginia, October 21, 2013 ?
avVaa World Health
Care Products? ("the Company") ("avVaa" or "the Company")
(Pink Sheets: AVVH)
Avvaa World Health Care Products Inc a leading
provider of a natural skin care product "Neuroskin", today
announced it has extended its distribution channel through a new
agreement with VP Plus Marketing a distributor of natural medical
products to Canadian Drugstores, Dermatologists and Natural Health
Stores.
Effective immediately the agreement entitles VP Plus Marketing the
rights to distribute Neuroskin?s Acne, Psoriasis, Itch Relief and
Rejuvenate products through all of western and central Canada. VP
Plus Marketing?s current network throughout the large number of
Pharmacies, will strengthen Avvaa World Health Care Products
presence in the Canadian market place. VP Plus Marketing presently
distributes Generic Pharma products, Natural OTC products and
medical devices in Canada.
"VP Plus Marketing?s network will definitely provide us with the
market penetration needed to reach our full sales potential in
Canada. Avvaa World Health Care Products has considered many
distribution partners in Canada and we are confident that VP Plus
Marketing?s 20 years of experience to bring new unique products to
market within the well respected Pharmacy retail sector will help
us leverage our position in the Canadian market," said Jason Price,
CEO
About avVaa World Health Care Products
avVaa World Health Care Products is a global biotechnology company
that specializes in effective, all natural, therapeutic skin care
products that improve quality of life and well being for
consumers. avVaa's patented European skin care formulas are
scientifically registered, FDA-Compliant, and were developed to
relieve and treat the symptoms of common skin ailments, including
eczema, psoriasis and acne. avVaa is poised to manufacture
and market its OTC Neuroskin? line of skin care products through
mass food and drug channels in the United States and
globally. The Company's secondary line of equine and pet care
related products are already being distributed throughout all of
Canada. For more information, visit: www.avvaa.com.
Jason Price Chairman & CEO
avVaa World Health Care Products
P: 1-866-864-6598
E: jason.price@avvaa.com www.avvaa.com
Pink Sheets: AVVH
Safe Harbor
This news release contains statements which may constitute
"forward-looking statements" within the meaning of the Securities
Act of 1933 and the Securities Exchange Act of 1934, as amended by
the Private Securities Litigation Reform Act of 1995. Those
statements include statements regarding the intent, belief or
current expectations of avVaa World Health Care Products, and
members of its management, as well as the assumptions on which such
statements are based. Prospective investors are cautioned
that any such forward-looking statements are not guarantees of
future performance and involve risks and uncertainties, and that
actual results may differ materially from those contemplated by
such forward-looking statements. Important factors currently
known to management that could cause actual results to differ
materially from those in forward-statements include fluctuation of
operating results, the ability to compete successfully and the
ability to complete before-mentioned transactions. The
Company undertakes no obligation to update or revise
forward-looking statements to reflect changed assumptions, the
occurrence of unanticipated events or changes to future operating
results. Potential risks and uncertainties include, but are
not limited to, the ability to procure, properly price, retain, and
successfully complete projects, the availability of technical
personnel, changes in technology, and competition.
Avvaa World Health Care ... (PK) (USOTC:AVVH)
Historical Stock Chart
From Jul 2024 to Aug 2024
Avvaa World Health Care ... (PK) (USOTC:AVVH)
Historical Stock Chart
From Aug 2023 to Aug 2024